Tag: PDX
Colorectal Cancer: A Biobank of Patient-derived Xenografts
According to GLOBOCAN 2018 data, colorectal cancer (CRC) is the third most deadly and fourth most commonly diagnosed cancer in the world. There were nearly 2 million new cases and about 1 million deaths in 2018. The incidence of...
BioLife Solutions’ CryoStor® Cell Freeze Media Evaluated In A PDX Banking Study
Xenografts using cancer cell lines in immunocompromised animal models have been used in research for many years, however there are concerns that these models do not adequately reflect the heterogeneity of an actual patient tumour. To overcome this patient-derived...
